NCT05096338 2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
Clinical Trials
11 trialsNCT07442578 2026-03-18
PULSE
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT06277388 2026-03-11
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Sun Yat-sen University
Active not recruiting
NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04305613 2025-10-02
CLARITY
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT05036252 2025-09-30
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT06597045 2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
NCT03748550 2024-08-21
EXACT2
Nova Scotia Health Authority
Phase NA Active not recruiting